Maxcyte Inc (MXCT)

Cost of Revenue

$6.39M

TTM · Period ending: · USD

MXCT logo

MXCT Cost of Revenue

Latest reported$6.39M
MXCT TTM Cost of Revenue ($957.50K → $6.39M)
High-resolution chart · PNG

MXCT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Maxcyte Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,386,000
6,230,000
5,142,000
5,813,000
7,225,000
7,194,000
7,100,000
6,392,100
5,257,100
5,145,100
4,742,100
4,715,500
5,291,400
5,035,800
5,098,400
4,777,800
4,352,700
4,016,800
3,647,300
3,328,300
3,119,300
2,801,100
2,767,000
2,588,100
2,581,300
2,636,599
2,499,198
2,314,448
2,129,698
1,984,849
1,840,000
1,698,850
1,557,700
1,505,400
1,453,100
1,419,000
1,384,900
1,346,250
1,307,600
1,224,350
1,141,100
1,086,450
1,031,800
1,027,600
1,023,400
990,450
957,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.